Related Experiment Video
Updated: Jul 14, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Interferon-induced depression in hepatitis C: an update.
1Department of Psychiatry and Behavioral Sciences, University of South Florida, MDC-14, Tampa, FL 33613, USA. bkeefe@health.usf.edu
Hepatitis C treatment with interferon-alpha (IFN) frequently causes depression. This review examines interferon-induced depression, exploring risk factors and effective antidepressant treatments, including prophylactic options.
Area of Science:
- Hepatology
- Psychiatry
- Pharmacology
Background:
- Hepatitis C represents a significant global health burden.
- Interferon-alpha (IFN) is the primary treatment, but commonly induces depression.
- Newer IFN formulations have not reduced depression rates.
Purpose of the Study:
- To review the epidemiology and risk factors of interferon-induced depression.
- To define interferon-induced depression as a distinct psychiatric entity.
- To outline evidence-based treatment strategies for this condition.
Main Methods:
- Literature review of studies on interferon-induced depression.
- Analysis of epidemiological data and risk factors.
- Evaluation of treatment approaches for depression in Hepatitis C patients.
Main Results:
- Interferon-induced depression affects over 25% of patients.
- Depression associated with IFN treatment is a significant clinical challenge.
- Prophylactic antidepressant treatment shows potential efficacy.
Conclusions:
- Interferon-induced depression warrants recognition as a unique psychiatric disorder.
- Comprehensive management strategies are crucial for patients undergoing IFN therapy.
- Further research into prophylactic antidepressant use is recommended.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Inhibitors Of Virion Release
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
